Inventor · disambiguated record
Lawrence R. Mcgee
Also filed as: MCGEE LAWRENCE · MCGEE LAWRENCE R
56 granted patents·26 pending applications·1,108 citations·filing 1992–2024
99Inventor score
Top patents by PatentIndex Score
82 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0497US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0597US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0696US6583157B2Quinolinyl and benzothiazolyl modulatorsTULARIK INC·Filed 2001·Granted Jun 24, 2003·64 cites·30 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0995US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1094US9623018B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Apr 18, 2017·6 cites·28 claims
- 1194US6200995B1PPAR-γ modulatorsTULARIK INC·Filed 1999·Granted Mar 13, 2001·143 cites·58 claims
- 1294US5656745ANucleotide analogsGILEAD SCIENCES INC·Filed 1993·Granted Aug 12, 1997·90 cites·29 claims
- 1393US6225460B1Nucleotide analogsGILEAD SCIENCES INC·Filed 1999·Granted May 1, 2001·132 cites·2 claims
- 1492US8623885B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3CHEN XIAOQI·Filed 2012·Granted Jan 7, 2014·44 cites·35 claims
- 1592US7041691B1Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2000·Granted May 9, 2006·38 cites·29 claims
- 1692US6770648B2Compounds for the modulation of PPARγ activityTULARIK INC·Filed 2002·Granted Aug 3, 2004·39 cites·58 claims
- 1791US8586739B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Nov 19, 2013·13 cites·7 claims
- 1891US8193199B2Heterocyclic compounds and their usesCHEN YI·Filed 2008·Granted Jun 5, 2012·15 cites·15 claims
- 1990US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 2090US7601841B2Quinolinyl and benzothiazolyl modulatorsAMGEN INC·Filed 2003·Granted Oct 13, 2009·19 cites·22 claims
- 2190US6620827B2PPARγ modulatorsTULARIK INC·Filed 2000·Granted Sep 16, 2003·36 cites·33 claims
- 2289US6034118AThiepane compoundsGILEAD SCIENCES INC·Filed 1995·Granted Mar 7, 2000·56 cites·36 claims
- 2389US5565449ANonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptorGENENTECH INC·Filed 1995·Granted Oct 15, 1996·42 cites·7 claims
- 2488US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 2588US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 2688US7968567B2Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2009·Granted Jun 28, 2011·8 cites·4 claims
- 2788US7223761B2Salts and polymorphs of a potent antidiabetic compoundAMGEN INC·Filed 2004·Granted May 29, 2007·32 cites·43 claims
- 2887US7960408B2Quinolinyl and benzothiazolyl modulatorsAMGEN INC·Filed 2009·Granted Jun 14, 2011·4 cites·16 claims
- 2987US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 3085US9801867B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Oct 31, 2017·2 cites·30 claims
- 3185US8003665B2Salts and polymorphs of a potent antidiabetic compoundAMGEN INC·Filed 2007·Granted Aug 23, 2011·8 cites·2 claims
- 3285US5886213APreparation of carbocyclic compoundsGILEAD SCIENCES INC·Filed 1997·Granted Mar 23, 1999·31 cites·3 claims
- 3384US5705524AThiepane compoundsGILEAD SCIENCES INC·Filed 1995·Granted Jan 6, 1998·33 cites·13 claims
- 3484US2023301974A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 3583US7439242B2PPARγ modulatorsAMGEN INC·Filed 2002·Granted Oct 21, 2008·14 cites·80 claims
- 3682US11352316B2Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 3782US7626033B2Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2004·Granted Dec 1, 2009·12 cites·46 claims
- 3880US8901135B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Dec 2, 2014·3 cites·16 claims
- 3980US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 4080US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 4179US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 4276US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 4376US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4475US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 4575US2022280496A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2021·Application pending·0 cites
- 4674US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 4774US2020281912A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2019·Application pending·0 cites
- 4873US9873701B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Jan 23, 2018·1 cites·16 claims
- 4973US7439350B2Nucleotide analogsGILEAD SCIENCES INC·Filed 2004·Granted Oct 21, 2008·4 cites·2 claims
- 5073US5859284APreparation of carbocyclic compoundsGILEAD SCIENCES INC·Filed 1996·Granted Jan 12, 1999·13 cites·3 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lawrence R. Mcgee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →